Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).
← catalyst calendarSponsored by LG Chem (industry) · 051910.KS — their whole pipeline →.
Phase
Phase 4
Status
Recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
248estimated
Sites
1
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-02-15 | actual | When the study began enrolling |
| Primary completion | 2025-09-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-06-30 | estimated | The whole study's end, after follow-up |
| First posted | 2025-04-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-04-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Female Infertility
Interventions
- Drug: Fang Le Shu (Follitrope)
- Drug: Guo Na Fen (Gonal-F)
Primary outcome
what the primary-completion date above is the date OFNumber of oocytes retrieved
measured 36 ± 3 hours after HGC trigger
Permalink · 051910.KS's whole pipeline · Catalyst calendar · Every registered study · What changed